MICkey icon

1.8 by SikeliUP


Aug 25, 2015

About MICkey

MICkey, antibiotic most effective

Mickey is a tool aimed to help all physicians prescriging antibiotics, and using as support the indications of a modern test of sensitivity to antimicrobial molecules, commonly known as susceptibility test.

The information provided by this test result in an indication of the likely effectiveness of the tested antibiotics (S:effective, I:uncertain efficacy, R: not effective) and the degree of vulnerability of the germ identified in each antibiotic marked with S. In order to quantify it, it is used a parameter called MIC (Minimum Inhibitory Concentration).

For each antibiotic indicated, together with the inclusion of its MIC, Mickey will identify the relative value of BreakPoint sensitivity, as published and validated by the EUCAST database (www.eucast.org).

The calculation of the ratio BreakPoint/MIC will produce the results placed in descending order, with the indication of the antibiotic most effective, based on the highest value of that ratio.

Mickey is an application that can be annually subscribed at the price of € 12,00, always up to date and constantly linked with the data published and validated by EUCAST.

What's New in the Latest Version 1.8

Last updated on Aug 25, 2015

Video Tutorial
Aggiornati valori di Break Point Tabella EUCAST - Clinical breakpoints - bacteria (v 5.0) -(2015-01-01)
(http://www.eucast.org/clinical_breakpoints/)

Translation Loading...

Additional APP Information

Latest Version

Request MICkey Update 1.8

Uploaded by

Azriel Firdaus Miftah Fariz

Requires Android

Android 3.0+

Show More

MICkey Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.